FDA Inspection 1276824 — Sofie Co

Sofie Co — FEI 3004977184

The FDA completed an inspection of Sofie Co on July 25, 2025 in Sterling, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sterling, VA (United States)

Citations

IDCFRDescription
1776421 CFR 212.20(e)Written QA procedures established, followed
1787721 CFR 212.70(c)Conform to specs prior to release